
AQIM-I is a highly мощный малая молекула survivin ингибитор by targeting ILF3/NF110, binds to ILF3/NF110 with KD value of 163 nM in SPR assays, has broad-spectrum antitumor activity.
AQIM-I is a highly potent small molecule survivin inhibitor by targeting ILF3/NF110, binds to ILF3/NF110 with KD value of 163 nM in SPR assays, has broad-spectrum antitumor activity.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.